Dr Reddy's Laboratories Ltd (RDY)

37.66
NYSE : Health Care
Prev Close 37.72
Day Low/High 37.38 / 37.83
52 Wk Low/High 29.83 / 50.10
Avg Volume 360.60K
Exchange NYSE
Shares Outstanding 165.80M
Market Cap 6.25B
EPS 1.10
P/E Ratio 33.98
Div & Yield 0.31 (0.80%)

Latest News

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr.

RDY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

RDY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr.

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr.

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr.

RDY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

RDY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a securities class action lawsuit against Dr.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Dr. Reddy's Laboratories Ltd.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Dr. Reddy's Laboratories Ltd.

The Klein Law Firm announces the commencement of an investigation of Dr.

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited

SHAREHOLDER ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr.

DR. REDDY LOSS NOTICE: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors Of Important Deadline In First Filed Class Action

DR. REDDY LOSS NOTICE: Rosen Law Firm Reminds Dr. Reddy's Laboratories Ltd. Investors Of Important Deadline In First Filed Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dr.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Dr. Reddy's Laboratories Limited And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Dr.

Dr. Reddy's Laboratories Breathes New Life Into Doan's® In New Marketing Campaign

Dr. Reddy's Laboratories Breathes New Life Into Doan's® In New Marketing Campaign

Dr. Reddy's Laboratories Ltd.

TheStreet Quant Rating: C (Hold)